These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 3883934)

  • 1. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
    Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
    Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluid homeostasis after heart transplantation: the role of cardiac denervation.
    Braith RW; Mills RM; Wilcox CS; Convertino VA; Davis GL; Limacher MC; Wood CE
    J Heart Lung Transplant; 1996 Sep; 15(9):872-80. PubMed ID: 8889982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone system and vasopressin in cyclosporine-treated renal allograft recipients.
    Stanek B; Kovarik J; Rasoul-Rockenschaub S; Silberbauer K
    Clin Nephrol; 1987 Oct; 28(4):186-9. PubMed ID: 3319308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect.
    Stahl RA; Kanz L; Maier B; Schollmeyer P
    Clin Nephrol; 1986 May; 25(5):245-8. PubMed ID: 3521998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of hyperkalemia in systemic lupus erythematosus.
    Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA
    Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of plasma renin activity by cyclosporine.
    Bantle JP; Boudreau RJ; Ferris TF
    Am J Med; 1987 Jul; 83(1):59-64. PubMed ID: 3300326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of oral glucose loading on the renin-angiotensin-aldosterone system in patients with chronic renal disease.
    Uemasu J; Fujihara M; Matsumoto T; Kawasaki H
    Horm Metab Res; 1993 Feb; 25(2):110-3. PubMed ID: 8458606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation to chronic potassium loading in normal man.
    Hené RJ; Koomans HA; Boer P; Dorhout Mees EJ
    Miner Electrolyte Metab; 1986; 12(3):165-72. PubMed ID: 3523191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation.
    Julien J; Farge D; Kreft-Jais C; Guyene TT; Plouin PF; Houssin D; Carpentier A; Corvol P
    Transplantation; 1993 Oct; 56(4):885-91. PubMed ID: 8212212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of the renal prostanoids to a short-term depletion of sodium or potassium in healthy women.
    Agnoli GC; Borgatti R; Cacciari M; Garutti C; Ikonomu E; Lenzi P; Marinelli M; Stipo L
    Boll Soc Ital Biol Sper; 1996; 72(3-4):109-16. PubMed ID: 8771911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nafamostat mesilate on the renin-aldosterone system].
    Okamoto T; Marukawa S; Hayami H; Ozaki K; Ishida H; Kono K
    Masui; 1992 Mar; 41(3):326-30. PubMed ID: 1560570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.